Navigation Links
Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics

Three Oritavancin Studies Presented at ECCMID/ICC

MUNICH, Germany, April 03, 2007 /PRNewswire/ -- Targanta Therapeutics today announced results from two studies showing the improved potency of oritavancin to stop bacterial growth in vitro when tested with a common wetting agent (polysorbate 80) and one study demonstrating the activity of oritavancin against S. pneumoniae in a mouse model of pneumonia. Oritavancin, a novel lipoglycopeptide antibiotic, is Targanta's lead product currently in post- Phase 3 clinical development. These findings were presented at the 17th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) and 25th International Congress of Chemotherapy (ICC) in Munich, Germany from March 31 - April 3, 2007.

"We are encouraged by the research demonstrating the improved activity of oritavancin when compared with other glycopeptide antibiotics. By combining oritavancin with a common wetting agent, it is evident that the ability of the treatment to inhibit bacteria growth, demonstrated through previous research, may be underestimated based on these recent studies," said Thomas Parr, Ph.D., Chief Scientific Officer, Targanta Therapeutics. "These data further support oritavancin as a potential treatment for serious bacterial infections, and Targanta will continue to explore this potential through ongoing clinical research."

    The following research was presented at the ECCMID/ICC meeting:

      --  Effect of polysorbate 80 on oritavancin binding to plastic surfaces

          -- implications for susceptibility testing (ECCMID/ICC07-P 1112)

      --  Influence of polysorbate 80 on susceptibility of gram-positive

          bacteria to oritavancin (ECCMID/ICC07-P 827)

      --  Efficacy of oritavancin in a mouse model of Streptococcus pneumoniae

          pneumonia (ECCMID/ICC07-P 1781)


    Study Methods and Results:

    --  Effect of polysorbate 80 on oritavancin binding to plastic surfaces --

        implic
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
10. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
11. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
Post Your Comments:
(Date:7/31/2014)... , July 31, 2014 Marken announced today ... facilities to meet the clinical trial logistics growth in ... newly expanded facility will continue to serve as a ... to and from the region, and will provide additional ... Marken will combine its office and warehouse into a ...
(Date:7/31/2014)... 2014 De Pfizer Clinical Research Unit (PCRU) ... vrijwilligers van Japanse komaf voor medewerking aan klinisch onderzoek. ... is één van twee onderzoekseenheden van Pfizer , ... verbeteren door de ontdekking en ontwikkeling van nieuwe medicijnen. ... naar mannen en vrouwen van Japanse komaf – leeftijd ...
(Date:7/30/2014)... , July 30, 2014  Cepheid (Nasdaq: ... purchasing contract with Premier will end on September ... GPO will be able to continue their relationship ... HPA, MedAssets, Novation, and ROi, in addition to ... with Cepheid. "Cepheid has always recognized ...
Breaking Medicine Technology:Marken Expands Miami Regional Logistics Center 2Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 3
(Date:7/31/2014)... Healthinsurancefacts.org has released a new blog post explaining how ... , In order to find affordable individual health ... can do this by visiting an insurance brokerage website ... should do proper research when looking for health insurance. ... of them can be advantageous in the appropriate context. ...
(Date:7/31/2014)... The National Cannabis Industry Association ... York on Thursday, August 7, from noon to 4pm ... keynotes by State Senator Diane J. Savino (D-Staten Island) ... include lunch and in-depth discussions on the recent passage ... is doing federally to advance a legitimate and responsible ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 According to a ... Bush recently underwent partial knee replacement surgery on his left ... than two months earlier. The story also reports that Bush ... and hopes to be back on the bike again soon. ... the benefits of partial knee replacement. , “Partial knee ...
(Date:7/31/2014)... ProtonPACS, a division of Radsource, has signed ... Health Association (NRHA), company officials announced today. The partnership ... of rural health providers nationwide. , “We are proud ... Dr. Mark Awh, President of Radsource. “While we are ... are also looking forward to learning from all of ...
(Date:7/31/2014)... (August 1, 2014) While it is known that members ... use alcohol, a new study finds that female enlistees ... than their civilian counterparts. This study was published today ... journal published on behalf of the Inter-University Seminar on ... and Lucky Tedrow studied surveys of nearly 9,000 men ...
Breaking Medicine News(10 mins):Health News:Comparing Health Insurance Quotes Can Help Clients Find Affordable Plans 2Health News:THURSDAY, AUG 7: First-Ever National Cannabis Industry Association Event in New York Will Feature Senator Savino, Assemblyman Katz, & Industry Leaders 2Health News:George W. Bush’s Surgery Highlights the Benefits of Partial Knee Replacement 2Health News:ProtonPACS Announces Pipeline Partnership with the National Rural Health Association. 2Health News:Women in military less likely to drink than civilian women 2
... of Infection Control and Hospital Epidemiology finds that ... Staphylococcus aureus (MRSA), and suggests that some nursing homes ... bacteria, which can lead to hard-to-treat infections. The study, ... found that 31 percent of the residents who were tested ...
... Mozes HealthDay Reporter , WEDNESDAY, Dec. 1 (HealthDay ... of radiation exposure from CT scans may be lower than ... to be presented Wednesday at the annual meeting of the ... an eight-year analysis of Medicare records covering nearly 11 million ...
... , WEDNESDAY, Dec. 1 (HealthDay News) -- Deployment to ... of sleep of many U.S. military personnel, new research ... members of the U.S. military before they deployed to ... Dec. 1 issue of the journal Sleep . ...
... , Glucocorticoid drugs are used widely to ... and some forms of cancer, and transplant recipients. The ... and immunosuppressive properties. However, their long-term use is limited ... glucose, fatty liver, and type 2 diabetes. A team ...
... Researchers from Boston University School of Medicine (BUSM) have ... agents can enter and kill cancer cells. This finding, which ... Journal of Virology , could help lead to the development ... The study was conducted by Ewan F. Dunn, a postdoctoral ...
... in French . Montreal, December 1st, 2010 ... more closely connected than previously imagined. The damaging effects of ... also affect the brain. In fact, infarction seems to cause ... to insomnia, notably paradoxical insomnia. Sleep plays a crucial role ...
Cached Medicine News:Health News:MRSA carriage rates vary widely in nursing homes, study finds 2Health News:CT Scans May Pose Less Cancer Risk Than Thought, Study Contends 2Health News:CT Scans May Pose Less Cancer Risk Than Thought, Study Contends 3Health News:Military Deployment May Lead to Unhealthy Sleep Patterns 2Health News:JCI online early table of contents: Dec. 1, 2010 2Health News:JCI online early table of contents: Dec. 1, 2010 3Health News:JCI online early table of contents: Dec. 1, 2010 4Health News:JCI online early table of contents: Dec. 1, 2010 5Health News:JCI online early table of contents: Dec. 1, 2010 6Health News:JCI online early table of contents: Dec. 1, 2010 7Health News:JCI online early table of contents: Dec. 1, 2010 8Health News:JCI online early table of contents: Dec. 1, 2010 9Health News:JCI online early table of contents: Dec. 1, 2010 10Health News:Insomnia after myocardial infarction 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: